Key Takeaways
- Akathisia is a severe inner restlessness with a drive to move that the person cannot switch off, and it is one of the less familiar symptoms of benzodiazepine withdrawal.
- It is easy to misread as the original anxiety returning, and the usual answer is a slower taper or a hold at the current dose, not another drug.
- Akathisia is a physical, compulsive need to move that stays constant whatever you do with your attention, while anxiety-related restlessness is more variable and often eases with distraction or an absorbing activity.
- Akathisia tends to worsen at predictable points tied to dose changes. Anxiety usually tracks worry, stressful events, or catastrophic thinking.
- The tension of akathisia sits deep in the legs and torso, often described as crawling under the skin or an inner vibration. Anxiety tension shows up more in the chest, shoulders, neck, and jaw, along with racing thoughts.
- Rapid tapering appears to raise the risk, and gentle movement, warm baths and fewer other stressors help many people through the worst of it.
- Keep a simple log of when symptoms are worst, what you were doing, and whether movement gave relief, and take it to the prescriber managing the taper. That is how the distinction is made in practice.
- Akathisia from withdrawal generally improves with time once the taper is slowed or stabilized, though the Maudsley Deprescribing Guidelines note it can be prolonged in some people. Thoughts of harming yourself are a reason to call or text 988, the Suicide and Crisis Lifeline.
Benzodiazepines are central nervous system depressants prescribed for anxiety disorders, panic disorders, insomnia, seizures, and muscle spasms. Taken regularly for more than a few weeks, they produce physical dependence, and reducing or stopping them then produces a withdrawal syndrome. That dependence is a predictable response to the medication, and dependence is not addiction.
Akathisia is one of the less familiar symptoms of that syndrome. It shows up as severe inner restlessness, an inability to remain still, and a drive to move that the person cannot switch off. Patients often describe it as wanting to crawl out of their own skin, pacing a room without finding any position that brings relief, or bouncing their legs under a desk no matter how hard they try to sit still. Because it arrives alongside a rise in anxiety, it is easy to misread as the original anxiety returning, and a prescriber who has not seen it before may respond by suggesting more medication. Recognizing it for what it is matters, because the usual answer is a slower taper or a hold at the current dose, not another drug.
Withdrawal symptoms in general come from changes in the gamma-aminobutyric acid (GABA) receptor system, which adapts to long-term benzodiazepine exposure and takes time to readjust when the drug is reduced. How soon akathisia appears, and how severe it is, depends on the specific benzodiazepine, the dose, how long it was taken, how fast it is being reduced, and individual factors such as age and other medical conditions. Short-acting benzodiazepines such as alprazolam can produce withdrawal symptoms within hours to days of a dose change, while long-acting medications such as diazepam may delay the onset. Symptoms range from mild restlessness to motor agitation severe enough to interfere with sleep, work, and social life. The Ashton Manual does not use the word akathisia; it lists excitability, jumpiness, and restlessness among the psychological symptoms of benzodiazepine withdrawal, and the severe, physical form described in this article is what patients and prescribers who work with withdrawal usually mean by the term.
Why Akathisia Happens During Withdrawal and What Helps
Mechanism. Benzodiazepines enhance GABA activity, and over time the GABA receptors adapt to that boost. When the dose falls, the brain has less inhibitory signaling than it has become used to. One proposed explanation for akathisia is that this loss of GABA inhibition allows overactivity in the dopamine pathways that control movement, similar to the akathisia seen with antipsychotic medications. That explanation is a hypothesis. Benzodiazepine withdrawal akathisia is well described clinically, but its mechanism is not settled.
Risk factors. Rapid tapering, high-dose or long-term use, other medicines taken at the same time (particularly antipsychotics and some antidepressants), and a previous episode of akathisia all appear to raise the risk.
Telling it apart from other conditions. A prescriber assessing akathisia looks at the quality of the restlessness, the drive to move, and the timing relative to dose changes, and rules out restless legs syndrome, anxiety disorders, agitated depression, and movement side effects from other medicines the person is taking.
Management. The first response is a taper adjustment: slowing the rate of reduction, or holding at the current dose until the symptom settles. That is consistent with the Ashton Manual’s advice that there is no need to hurry withdrawal and that a person can stay at a dose for a few weeks if necessary. Some prescribers use short courses of other medicines for severe akathisia; whether that is appropriate is a prescriber decision made case by case, and anything that blocks dopamine should be avoided. Gentle movement, warm baths, and reducing other sources of stress help many people get through the worst of it.
Outlook. Most cases resolve within weeks to months as receptor function normalizes, once the taper is stabilized or completed. Protracted cases can persist longer but generally improve with time. Early recognition and a change in taper pace improve the outcome.
Severe akathisia is exhausting, and people in the middle of it sometimes describe despair or a sense of being trapped in their own body. If you have thoughts of harming yourself, call or text 988, the Suicide and Crisis Lifeline in the United States. Call 911 for a seizure or any other medical emergency. Otherwise, keep in close communication with your prescriber, and if symptoms are severe or do not respond to a slower taper, ask about a consultation with a physician experienced in benzodiazepine withdrawal.
How to Differentiate Akathisia from Anxiety During Benzodiazepine Withdrawal
- Assess the physical component. Akathisia is an overwhelming physical need to move that feels impossible to resist. Anxiety can make you restless, but it does not usually create that compulsive motor drive. Notice whether the urge to move starts in your muscles and body or mainly in worried thoughts.
- Look at the pattern of movement. With akathisia you will notice repetitive movements: pacing, rocking, shifting weight from foot to foot, or being unable to sit still even briefly. Anxiety-related restlessness is less rhythmic and more variable, and it often eases when you are distracted or absorbed in an activity.
- Track the timing and triggers. Akathisia tends to worsen at predictable points tied to dose changes or the stage of the taper, and it is not necessarily connected to stressful situations or anxious thoughts. Anxiety symptoms usually track worry triggers, stressful events, or catastrophic thinking.
- Check where the tension sits. Akathisia creates a deep, uncomfortable sensation often described as crawling under the skin or an inner vibration, particularly in the legs and torso. Anxiety tension shows up more in the chest, shoulders, neck, and jaw, along with racing thoughts rather than purely physical discomfort.
- Note your response to distraction. Anxiety often improves for a while with distraction, breathing exercises, or cognitive techniques. Akathisia stays constant no matter what you do with your attention, because it is a neurological symptom rather than a psychological one.
- Log symptom severity through the day. Keep a simple record of when symptoms are worst, what you were doing, and whether movement gave any relief. Akathisia usually shows a consistent pattern related to medication timing, while anxiety rises and falls with psychological stressors.
- Take the log to your prescriber. Bring your record to the physician managing your taper. The distinction matters because the two conditions call for different responses: akathisia usually calls for a slower step or a hold, while a return of anxiety is handled differently, and an accurate read of which one you have shapes the rest of the taper.
Frequently Asked Questions About Benzo Withdrawal Akathisia
Can akathisia occur at any point during benzodiazepine withdrawal?
Yes. It most often appears during rapid tapers or in the acute phase after a reduction, but some people develop it weeks into withdrawal as the nervous system continues to adjust. The timing varies with the specific benzodiazepine, the length of use, the taper speed, and individual sensitivity.
Is akathisia from benzo withdrawal permanent?
No. Akathisia related to benzodiazepine withdrawal is not permanent and resolves as the nervous system heals, though the timeline varies considerably between individuals. Most people improve gradually over weeks to months after completing the taper or stabilizing on a dose. In rare cases symptoms persist longer as part of a protracted withdrawal, but the outlook for resolution is generally favorable.
What makes akathisia worse during benzodiazepine withdrawal?
Rapid dose reductions, poor sleep, high stress, caffeine, and medicines that act on dopamine or GABA systems can all make it worse. Physical exhaustion from constant movement can feed a cycle that intensifies symptoms. Many patients find that a slow, gradual taper and fewer other stressors on the nervous system keep severe episodes at bay.
Can you treat akathisia while still tapering benzodiazepines?
Yes. Slowing the taper rate or holding at the current dose often brings relief by giving the nervous system more time to adjust. Any medicine added on top of that is a case-by-case decision for the prescriber, as described in the Management paragraph above, and should be weighed carefully given how sensitive the nervous system already is during withdrawal.
How do doctors diagnose akathisia versus severe anxiety?
Physicians diagnose akathisia clinically, focusing on the quality of the restlessness, the compulsive need to move, and the timing relative to medication changes. They ask whether the symptom improves with movement, look for the characteristic inner tension, review the medication history, and rule out other conditions that can look similar.
Understanding Akathisia as a Neurological Symptom
Akathisia is a movement disorder marked by an intense, subjective feeling of inner restlessness together with a compelling need to move. The term comes from Greek and literally means “inability to sit.” It is most often associated with antipsychotic medications, but it can occur during withdrawal from benzodiazepines and other substances that act on the central nervous system, where it reflects a mismatch between the brain’s motor control systems and the subjective sense of comfort at rest.
The hallmark is the combination of subjective distress and visible motor restlessness. Patients describe crawling under the skin, an inner vibration, or an unbearable tension that movement relieves only for a moment. This is fundamentally different from ordinary anxiety or fidgeting, because the drive to move is physical and involuntary rather than psychological. Common signs include pacing, rocking while standing, marching in place, crossing and uncrossing the legs, and being unable to stay seated for normal periods.
Akathisia runs from mild to severe. At its worst it interferes with sleep, concentration, and daily functioning, and its relentless quality can cause real psychological distress. Recognizing it as a distinct neurological symptom rather than “just anxiety” matters, because the response is different: for akathisia in withdrawal, the first move is almost always a slower or paused taper. For the broader question of telling withdrawal from a return of the original anxiety, see the site’s article on telling benzo withdrawal from a return of anxiety. To see how a slower reduction schedule is laid out, the benzodiazepine taper calculator on this site illustrates gradual, stepwise reductions as an educational planning tool.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.
